http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5995293-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_584b49b1d4f25de6fcc7295680157d0e |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
filingDate | 1982-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4becb211fc28179c11c1fbe918bbf605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260bd17061d58aa37d335d2727bcb1eb |
publicationDate | 1984-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S5995293-A |
titleOfInvention | Organogermanium compound |
abstract | NEW MATERIAL:A compound shown by the formula I (X is halogen). n USE: An antimetabolite for inhibiting DNA synthesis of tumor cell. n PROCESS: For example, a uracil halogen derivative shown by the formula II is acetylated with acetyl chloride, etc. to give a diacetyl derivative shown by the formula III, to which trichlorogermane is added in a solvent such as chloroform, etc., to give a trichlorogermyl derivative shown by the formula IV. This compound is then hydrolyzed, to give a compound shown by the formula I . n COPYRIGHT: (C)1984,JPO&Japio |
priorityDate | 1982-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.